DNA nanomedicine: Engineering DNA as a polymer for therapeutic and diagnostic applications

被引：68

作者：

Campolongo, Michael J. ^{[2
]}

Tan, Shawn J. ^{[2
]}

Xu, Jianfeng ^{[3
]}

Luo, Dan ^{[1
]}

机构：

[1] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA

[2] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA

[3] Arkansas State Univ, Arkansas Biosci Inst, State Univ, AR 72467 USA

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2010年 / 62卷 / 06期

关键词：

DNA; Nanomedicine; Polymer topologies; Nano-assembly; DNA nanostructures; SINGLE-NUCLEOTIDE POLYMORPHISM; BIO-BARCODE ASSAY; EXPONENTIAL ENRICHMENT; COLORIMETRIC DETECTION; MULTIPLEXED DETECTION; SYSTEMATIC EVOLUTION; NANOPARTICLE PROBES; EMERGING CLASS; BASIC RESEARCH; DRUG-DELIVERY;

D O I：

10.1016/j.addr.2010.03.004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Nanomedicine, the application of nanotechnology to medicine, encompasses a broad spectrum of fields including molecular detection, diagnostics, drug delivery, gene regulation and protein production. In recent decades, DNA has received considerable attention for its functionality and versatility, allowing it to help bridge the gap between materials science and biological systems. The use of DNA as a structural nanoscale material has opened a new avenue towards the rational design of DNA nanostructures with different polymeric topologies. These topologies, in turn, possess unique characteristics that translate to specific therapeutic and diagnostic strategies within nanomedicine. (C) 2010 Elsevier By. All rights reserved.

引用

页码：606 / 616

页数：11

共 157 条

[21] Advances in the development of therapeutic nucleic acids against cervical cancer [J].

DiPaolo, JA ;

Alvarez-Salas, LM .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) :1251-1264

[22] Adaptive liquid microlenses activated by stimuli-responsive hydrogels [J].

Dong, Liang ;

Agarwal, Abhishek K. ;

Beebe, David J. ;

Jiang, Hongrui .

NATURE, 2006, 442 (7102) :551-554

[23] DNA vaccines: Progress and challenges [J].

Donnelly, JJ ;

Wahren, B ;

Liu, MA .

JOURNAL OF IMMUNOLOGY, 2005, 175 (02) :633-639

[24] Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys [J].

Drolet, DW ;

Nelson, J ;

Tucker, CE ;

Zack, PM ;

Nixon, K ;

Bolin, R ;

Judkins, MB ;

Farmer, JA ;

Wolf, JL ;

Gill, SC ;

Bendele, RA .

PHARMACEUTICAL RESEARCH, 2000, 17 (12) :1503-1510

[25] An enzyme-linked oligonucleotide assay [J].

Drolet, DW ;

MoonMcDermott, L ;

Romig, TS .

NATURE BIOTECHNOLOGY, 1996, 14 (08) :1021-1025

[26]

Drolet DW, 1999, COMB CHEM HIGH T SCR, V2, P271

[27] Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles [J].

Elghanian, R ;

Storhoff, JJ ;

Mucic, RC ;

Letsinger, RL ;

Mirkin, CA .

SCIENCE, 1997, 277 (5329) :1078-1081

[28] INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS [J].

ELLINGTON, AD ;

SZOSTAK, JW .

NATURE, 1990, 346 (6287) :818-822

[29] Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy [J].

Famulok, Michael ;

Hartig, Jorg S. ;

Mayer, Gunter .

CHEMICAL REVIEWS, 2007, 107 (09) :3715-3743

[30] Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo [J].

Farokhzad, OC ;

Cheng, JJ ;

Teply, BA ;

Sherifi, I ;

Jon, S ;

Kantoff, PW ;

Richie, JP ;

Langer, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6315-6320

← 1 2 3 4 5 6 7 8 9 10 →